Oramed Pharmaceuticals Inc..
ORMP.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Oramed Pharmaceuticals Inc. is a pharmaceutical company focused on the development of oral drug delivery systems. Its primary focus is on developing oral insulin capsules for the treatment of diabetes. The company's technology aims to protect orally administered drugs from degradation in the gastroi...Show More
Better Health for All
0
No relevant and verifiable data was found across the provided articles to assess Oramed Pharmaceuticals Inc. against any of the 'Better Health for All' KPIs. The articles either resulted in 404 errors
1
or contained information unrelated to the company's performance on ethical metrics
2
, despite one article's title suggesting relevance to Oramed.
3
Fair Money & Economic Opportunity
0
No evidence available to assess Oramed Pharmaceuticals Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
No specific, quantifiable data was found in the provided articles for any of the KPIs related to Fair Pay & Worker Respect. The articles primarily focus on financial performance, executive compensation in comparison to industry averages (not the CEO to median employee pay ratio within the company), and clinical trial results.
1
Several articles explicitly state the absence of data for metrics such as living wage coverage, collective bargaining share, safety incident rates, pay equity, worker engagement, turnover rates, labor violation incidents, insecure contract share, or health insurance coverage for the workforce.
2
While one employment agreement mentions health insurance for a single employee, this does not provide a percentage for the entire workforce.
3
Fair Trade & Ethical Sourcing
0
No specific, quantitative, or qualitative evidence regarding fair trade and ethical sourcing practices, supplier audits, forced/child labor incidents, supply chain traceability, remediation speed for supplier violations, ethical clauses in supplier contracts, high-risk materials spend, or supplier diversity spend was found in the provided articles.
1
The articles primarily discuss financial matters, general corporate information, or an internal code of ethics for employees, none of which provide data relevant to the specified KPIs for supplier practices.
2
Honest & Fair Business
0
No evidence available to assess Oramed Pharmaceuticals Inc. on Honest & Fair Business.
Kind to Animals
-50
The company conducts animal studies for its product development, including preclinical and comprehensive toxicity studies under FDA Good Laboratory Practices regulations.
1
Animal studies were successfully completed for the Phase 1B clinical trial of oral insulin capsule (ORMD0801) in November 2007, for pre-clinical trials of ORMD0901 in September 2008, and involved pigs for combination treatments in June 2012.
2
Preclinical data for Oravax also showed safety and efficacy in animal studies.
3
However, no specific animal testing policy is mentioned in the provided articles.
No War, No Weapons
0
No evidence available to assess Oramed Pharmaceuticals Inc. on No War, No Weapons.
Planet-Friendly Business
-30
In 2023, Oramed Pharmaceuticals reported a carbon footprint of 1,850 tCO₂e, which represents a 14.94% reduction from 2,175 tCO₂e in 2022.
1
The company invested $750,000 in carbon offsets in 2023, an increase from $500,000 in 2022.
2
Oramed reported 100% adherence to FDA regulatory reporting requirements and 100% compliance with international clinical trial regulations, with no ongoing regulatory challenges or violations.
3
In 2023, the company identified 12 potential areas for environmental impact improvement.
4
Respect for Cultures & Communities
0
No evidence was found in the provided articles to assess Oramed Pharmaceuticals Inc. against any of the KPIs for the 'Respect for Cultures & Communities' value. The articles focus on governance documents, clinical trials, a code of ethics, and regulatory approvals, none of which contain specific data points related to community engagement, cultural preservation, local employment, or related metrics.
Safe & Smart Tech
0
The company states that it conducts vulnerability assessments and utilizes cybersecurity threat intelligence.
1
Its cybersecurity measures include firewalls, intrusion prevention/detection systems, anti-malware, and access controls.
2
The Chief Operating and Business Officer is responsible for implementing protection measures and responding to incidents.
3
The company's privacy statement indicates that users can unsubscribe from email lists and that data related to email subscriptions is retained until a user unsubscribes.
4
It also mentions compliance with GDPR and other relevant regulations.
5
The company has stated that cybersecurity risks have not materially affected them and are not reasonably likely to impact their business strategy, operations, or financial condition.
6
However, no specific data breaches, quantitative cybersecurity investment figures, details on encryption, or information regarding AI ethics or algorithmic transparency are provided.
Zero Waste & Sustainable Products
0
No specific, concrete data points were found in the provided articles to assess Oramed Pharmaceuticals Inc. against any of the Zero Waste & Sustainable Products KPIs.
1
The articles were either placeholders, explicitly stated a lack of relevant data, or could not be accessed, thus providing no evidence for scoring.
2